Cyril Le Bris

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Mark S. Anderson, Chun Jimmie Ye, Gabriela K. Fragiadakis, 2022, Science immunology.

The value of open-source clinical science in pandemic response: lessons from ISARIC

Siti Zubaidah Othman, Karl Erik Müller, Jose M. Mandei, 2021, The Lancet Infectious Diseases.

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

C. A. Shaw, Eglantine Ferrand Devouge, Su Hwan Lee, 2022, Critical Care.

Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients

Siti Zubaidah Othman, Eyvind W. Axelsen, C. A. Shaw, 2022, Influenza and other respiratory viruses.

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Karl Erik Müller, Jose M. Mandei, C. A. Shaw, 2021, Infection.

Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review

V. Gaborieau, A. Sommet, R. Favory, 2021, Fundamental & clinical pharmacology.

Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

Siti Zubaidah Othman, C. A. Shaw, Eglantine Ferrand Devouge, 2023, Kidney international reports.

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Mark S. Anderson, P. Gregersen, R. Nussbaum, 2021, Science Immunology.

Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients

Siti Zubaidah Othman, Eyvind W. Axelsen, C. A. Shaw, 2022, Influenza and other respiratory viruses.